Adjacent Evidence Brief: Telomere Cancer Effects

Artifact

Living evidence brief from agent-v3-full-paper-live

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Populate the Key Findings section with a concrete bullet list tied to the explicit outcome-class slices, naming which sources support each bullet.
2. Restate the research question to match the two-part claim in the abstract (prognostic value of shorter LTL for survival; causal-risk direction of genetically predicted longer LTL) and explicitly answer both halves in the body.
3. Reconcile the corpus-size claims (e.g., 'n=7 causal-risk/MR', '25 sources', 'n=17 contextual') with the actual supplied bundle and the funnel counts; correct any overcounts or label them as 'classified' vs 'admitted' consistently.
4. Move direction-coding 'unclear' status to a more visible position in the narrative so readers know that the bulk of significant statistics in this corpus are polarity-unsigned at extraction.
5. Reduce redundant repetition of the evidence-honesty note across Abstract, Research Question, and Conclusion.

Major issues

• The Key Findings section is empty apart from the outcome-class note — the manuscript lacks the actual bullet/narrative findings list required for the rapid-synthesis template.
• The research question is phrased vaguely ('What does the retained source corpus establish about Telomere Cancer Effects?') rather than the specific comparative claim stated in the abstract (shorter LTL predicts worse cancer survival AND genetically predicted longer LTL increases incident cancer risk across tumor types). The abstract thesis is not directly answered in the body.
• The conclusion counts 'causal-risk and Mendelian-randomization evidence n=7' but the source bundle contains only ~3 MR sources (Markozannes 2022, Chen 2023, Wan 2023, Song 2022), and no 'n=7' direct causal-risk sources are visible. Internal inconsistency between the claimed corpus breakdown and the supplied bundle.

Minor issues

• Search summary window date (2026-06-27) is a single-day 'frozen' snapshot; should clarify that this is an index date rather than a comprehensive date range.
• Several 2026-dated DOIs are present in the bundle — these appear to be in-press/early-vintage records; briefly note retrieval status.
• Direction coding is 'unclear' for the majority of significant-statistic sources (15/17 in the largest slice); the reconciliation note is appropriate but the manuscript does not surface this prominently enough to constrain interpretation.
• Outcome class names vary in capitalization/style across sections.
• The abstract's evidence-honesty note is repeated verbatim in Research Question and again in Conclusion, creating redundancy.

Reviewer note

The submission is a thin-corpus evidence brief on telomere-cancer effects with explicit search scope, a reproducible audit trail, and a tiered, evidence-honest framing that appropriately declines to escalate into clinical or policy claims. The source bundle is generally well-matched to cited_as entries, recent, and spans prognostic, Mendelian-randomization, and mechanistic literatures. Major issues are structural rather than evidentiary: the Key Findings section is empty, the research question does not match the two-part thesis stated in the abstract, and the corpus-size narrative claims (notably n=7 MR/causal-risk) do not align with the supplied bundle. The conclusion's tiered, bounded reading is appropriate and the limitations section correctly identifies evidence-role imbalance and endpoint heterogeneity. With the Key Findings populated, the research question aligned to the abstract thesis, and the corpus counts reconciled to the actual bundle, this becomes a competent rapid synthesis. Recommend revise.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis